Today CareFusion (CFN) Hits New Lifetime High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified CareFusion ( CFN) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified CareFusion as such a stock due to the following factors:

  • CFN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $41.0 million.
  • CFN has traded 10,633 shares today.
  • CFN is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CFN with the Ticky from Trade-Ideas. See the FREE profile for CFN NOW at Trade-Ideas

More details on CFN:

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, and respiratory care. CFN has a PE ratio of 23.4. Currently there are 5 analysts that rate CareFusion a buy, no analysts rate it a sell, and 5 rate it a hold.

The average volume for CareFusion has been 1.3 million shares per day over the past 30 days. CareFusion has a market cap of $9.3 billion and is part of the health care sector and health services industry. The stock has a beta of 0.90 and a short float of 1.6% with 3.13 days to cover. Shares are up 15.3% year-to-date as of the close of trading on Friday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Jim Cramer: The S&P 500 Isn’t as Passive as You Might Think

Jim Cramer's 'Mad Money' Recap: This Is One Stupid Market

3 Stocks Reiterated As A Buy: CFN, UTX, WHR

Insider Trading Alert - CFN, VSR And CAVM Traded By Insiders

Jim Cramer on the Stock Market: Spinoffs Are in Vogue